Thrombocytopenia: Perioperative Considerations for Patients Undergoing Cardiac Surgery.

The etiologies of thrombocytopenia in patients presenting for cardiac surgery are extensive, but clinically relevant conditions generally can be categorized by those related to decreased platelet production or increased platelet destruction. Many causes require mere acknowledgment and availability of allogeneic platelet transfusion; others have unique considerations for which providers should be familiar. The purpose of this review is to provide an overview of the common causes of thrombocytopenia, summarize the literature, and discuss perioperative considerations for patients undergoing cardiac surgery.

[1]  G. Souto,et al.  Thrombocytopenia-Absent Radius (TAR): Case report of dental implant and surgical treatment , 2020, Journal of clinical and experimental dentistry.

[2]  Ingrid Moreno-Duarte,et al.  Clinical outcomes of cardiac surgery patients undergoing therapeutic plasma exchange for heparin‐induced thrombocytopenia , 2020, Vox sanguinis.

[3]  J. Raval,et al.  Therapeutic plasma exchange and intravenous immune globulin in the treatment of heparin‐induced thrombocytopenia: A systematic review , 2020, Transfusion.

[4]  A. Neff,et al.  Perioperative Management of a Patient With Profound Thrombocytopenia Secondary to MYH9-RD Presenting for Thoracic Aortic Aneurysm Repair and Aortic Valve Replacement. , 2020, Journal of cardiothoracic and vascular anesthesia.

[5]  A. Koster,et al.  High‐dose IVIG plus cangrelor platelet “anesthesia” during urgent heparin‐CPB in a patient with recent SRA‐negative HIT‐thrombosis with persisting platelet‐activating antibodies , 2020, Research and practice in thrombosis and haemostasis.

[6]  S. Vesely,et al.  ISTH guidelines for treatment of thrombotic thrombocytopenic purpura , 2020, Journal of thrombosis and haemostasis : JTH.

[7]  M. Othman,et al.  Guidance on the diagnosis and management of platelet‐type von Willebrand disease: A communication from the Platelet Physiology Subcommittee of the ISTH , 2020, Journal of thrombosis and haemostasis : JTH.

[8]  W. Auger,et al.  Cangrelor and Heparin for Pulmonary Thromboendarterectomy in Heparin-Induced Thrombocytopenia. , 2020, The Annals of thoracic surgery.

[9]  M. Boswell,et al.  Thrombocytosis: Perioperative Considerations for Patients Undergoing Cardiac Surgery. , 2020, Journal of cardiothoracic and vascular anesthesia.

[10]  L. Alberio,et al.  Potential and Limitations of the New P2Y12 Inhibitor, Cangrelor, in Preventing Heparin-Induced Platelet Aggregation During Cardiac Surgery: An In Vitro Study , 2020, Anesthesia and analgesia.

[11]  J. Bussel,et al.  Updated international consensus report on the investigation and management of primary immune thrombocytopenia. , 2019, Blood advances.

[12]  G. Laguna,et al.  Gray platelet syndrome: Management of perioperative bleeding in redo cardiac surgery , 2019, Journal of cardiac surgery.

[13]  Raja R. Palvadi,et al.  Society of Cardiovascular Anesthesiologists Clinical Practice Improvement Advisory for Management of Perioperative Bleeding and Hemostasis in Cardiac Surgery Patients. , 2019, Journal of cardiothoracic and vascular anesthesia.

[14]  P. Gresele,et al.  Eltrombopag in preparation for surgery in patients with severe MYH9‐related thrombocytopenia , 2019, American journal of hematology.

[15]  T. Warkentin.  High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review , 2019, Expert review of hematology.

[16]  Supriya Sharma,et al.  Management of haemostasis during dental extraction in a Bernard-Soulier syndrome child , 2019, BMJ Case Reports.

[17]  A. Kittang,et al.  Treatment of myelodysplastic syndrome in the era of next‐generation sequencing , 2019, Journal of internal medicine.

[18]  A. Tefferi,et al.  3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk‐Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups , 2018, Mayo Clinic proceedings.

[19]  M. Mehra,et al.  Development of Multidisciplinary Anticoagulation Management Guidelines for Patients Receiving Durable Mechanical Circulatory Support , 2019, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[20]  Jonathan Klick,et al.  Heparin-Induced Thrombocytopenia: A Review for Cardiac Anesthesiologists and Intensivists. , 2019, Journal of cardiothoracic and vascular anesthesia.

[21]  M. Maniati,et al.  Thrombocytopenia in solid tumors: Prognostic significance , 2019, Oncology reviews.

[22]  K. Node,et al.  Acute Mitral Regurgitation of Unknown Etiology Associated with Disseminated Intravascular Coagulation Eventually Diagnosed as Enterococcus Faecalis Infective Endocarditis by Mitral Valve Surgery , 2018, The American journal of case reports.

[23]  P. Benharash,et al.  Heparin‐induced thrombocytopenia in cardiac surgery: Incidence, costs, and duration of stay☆ , 2018, Surgery.

[24]  A. Hvas,et al.  Platelet Function During Extracorporeal Membrane Oxygenation in Adult Patients: A Systematic Review , 2018, Front. Cardiovasc. Med..

[25]  B. Zieger,et al.  Acquired von Willebrand syndrome and impaired platelet function during venovenous extracorporeal membrane oxygenation: Rapid onset and fast recovery. , 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[26]  S. Dahal,et al.  Myocardial Infarction as an Early Presentation in Thrombotic Thrombocytopenic Purpura: A Rare Case Series , 2018, Journal of investigative medicine high impact case reports.

[27]  C. Wiedermann,et al.  Antithrombin concentrate use in disseminated intravascular coagulation of sepsis: meta‐analyses revisited , 2018, Journal of thrombosis and haemostasis : JTH.

[28]  P. Rebulla,et al.  Platelet Transfusion for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  T. Biss,et al.  Descending aortic aneurysm in Wiskott-Aldrich syndrome: options for repair , 2017, Asian cardiovascular & thoracic annals.

[30]  S. Verstovsek,et al.  The underappreciated risk of thrombosis and bleeding in patients with myelofibrosis: a review , 2017, Annals of Hematology.

[31]  R. Benjamin,et al.  Improved Outcomes With the Evolution of a Neoadjuvant Chemotherapy Approach to Right Heart Sarcoma. , 2017, The Annals of thoracic surgery.

[32]  A. Tefferi,et al.  Leukemic Transformation in Myeloproliferative Neoplasms: A Literature Review on Risk, Characteristics, and Outcome , 2017, Mayo Clinic proceedings.

[33]  J. Espinoza,et al.  Microbe-Induced Inflammatory Signals Triggering Acquired Bone Marrow Failure Syndromes , 2017, Front. Immunol..

[34]  P. Coppo,et al.  Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies , 2017, Journal of thrombosis and haemostasis : JTH.

[35]  Joan Cid,et al.  Transfusion reactions: prevention, diagnosis, and treatment , 2016, The Lancet.

[36]  A. Tefferi,et al.  Primary myelofibrosis: 2017 update on diagnosis, risk‐stratification, and management , 2016 .

[37]  K. Fukino,et al.  Acute Myocardial Infarction Caused by Thrombotic Microangiopathy Complicated With Myelodysplastic Syndrome. , 2016, International heart journal.

[38]  J. Shaw,et al.  Mechanical circulatory support is associated with loss of platelet receptors glycoprotein Ibα and glycoprotein VI , 2016, Journal of thrombosis and haemostasis : JTH.

[39]  G. Weigel,et al.  Predicting Transfusion Requirements During Extracorporeal Membrane Oxygenation. , 2016, Journal of cardiothoracic and vascular anesthesia.

[40]  R. Suojaranta-Ylinen,et al.  Decreased maximum clot firmness in rotational thromboelastometry (ROTEM®) is associated with bleeding during extracorporeal mechanical circulatory support , 2016, Perfusion.

[41]  Xingmin Feng,et al.  Thrombopoietic status of patients on haemodialysis , 2016, British journal of haematology.

[42]  M. Othman,et al.  Platelet type von Willebrand disease and registry report: communication from the SSC of the ISTH , 2016, Journal of thrombosis and haemostasis : JTH.

[43]  M. Georgieff,et al.  Helicobacter pylori Infection Induces Anemia, Depletes Serum Iron Storage, and Alters Local Iron-Related and Adult Brain Gene Expression in Male INS-GAS Mice , 2015, PloS one.

[44]  N. Parikh,et al.  A Case Report: Jacobsen Syndrome Complicated by Paris-Trousseau Syndrome and Shone’s Complex , 2015, Journal of pediatric hematology/oncology.

[45]  R. Pruthi,et al.  False Lumen Embolization to Treat Disseminated Intravascular Coagulation After Thoracic Endovascular Aortic Repair of Type B Aortic Dissection , 2015, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[46]  R. Jain,et al.  Thrombocytosis following splenectomy and aortic valve replacement for idiopathic thrombocytopaenic purpura with bicuspid aortic valve , 2015, Indian journal of anaesthesia.

[47]  Ece Altınay,et al.  Pulmonary Endarterectomy in a Patient with Immune Thrombocytopenic Purpura , 2015, Case reports in vascular medicine.

[48]  M. B. Macêdo,et al.  Primigravida with Bernard-Soulier Syndrome: a case report , 2015, BMC Research Notes.

[49]  P. Jansz,et al.  Prospective observational study of hemostatic alterations during adult extracorporeal membrane oxygenation (ECMO) using point-of-care thromboelastometry and platelet aggregometry. , 2015, Journal of cardiothoracic and vascular anesthesia.

[50]  William R Wagner,et al.  Real time visualization and characterization of platelet deposition under flow onto clinically relevant opaque surfaces. , 2015, Journal of biomedical materials research. Part A.

[51]  B. Zieger,et al.  Identification of acquired coagulation disorders and effects of target-controlled coagulation factor substitution on the incidence and severity of spontaneous intracranial bleeding during veno-venous ECMO therapy , 2015, Perfusion.

[52]  H. El,et al.  Post‐Transfusion Purpura Following Cardiac Surgery , 2015, Journal of cardiac surgery.

[53]  T. Gruenberger,et al.  Deficiency in Thrombopoietin Induction after Liver Surgery Is Associated with Postoperative Liver Dysfunction , 2015, PloS one.

[54]  A. Prica,et al.  Safety and efficacy of thrombopoietin‐receptor agonists in myelodysplastic syndromes: a systematic review and meta‐analysis of randomized controlled trials , 2014, British journal of haematology.

[55]  H. Burkhart,et al.  Perioperative management of patients with DiGeorge syndrome undergoing cardiac surgery. , 2014, Journal of cardiothoracic and vascular anesthesia.

[56]  Jacob P. Kelly,et al.  ST-segment elevation myocardial infarction treated with thrombolytic therapy in a patient with thrombotic thrombocytopenic purpura , 2014, Journal of Thrombosis and Thrombolysis.

[57]  SC Body,et al.  Restoration of the coagulation cascade on CPB: a case report , 2014, Perfusion.

[58]  R. Pruthi,et al.  Operative and nonoperative management of chronic disseminated intravascular coagulation due to persistent aortic endoleak. , 2014, Journal of vascular surgery.

[59]  Y. Maehara,et al.  Management of thrombocytopenia due to liver cirrhosis: a review. , 2014, World journal of gastroenterology.

[60]  F. Naz,et al.  Aortic valve replacement in a patient with pancytopenia secondary to myelodysplastic syndrome. , 2014, JPMA. The Journal of the Pakistan Medical Association.

[61]  L. Bernal-Mizrachi,et al.  Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies , 2013, Cancer.

[62]  D. Lambert,et al.  Endovascular repair of descending thoracic aortic aneurysm in patient with Wiskott-Aldrich syndrome. , 2013, Journal of vascular surgery.

[63]  R. Favier,et al.  First Successful Use of Eltrombopag Before Surgery in a Child With MYH9-Related Thrombocytopenia , 2013, Pediatrics.

[64]  Y. Ozaki,et al.  Platelet receptors activated via mulitmerization: glycoprotein VI, GPIb‐IX‐V, and CLEC‐2 , 2013, Journal of thrombosis and haemostasis : JTH.

[65]  L. Weinberg,et al.  Post-Cardiac Surgery Thrombotic Thrombocytopenic Purpura with Digital Ischaemia , 2013, Anaesthesia and intensive care.

[66]  J. Thachil,et al.  Guidance for diagnosis and treatment of disseminated intravascular coagulation from harmonization of the recommendations from three guidelines , 2013, Journal of thrombosis and haemostasis : JTH.

[67]  Vivek Chowdhry,et al.  Cardiac surgery in a patient with immunological thrombocytopenic purpura: complications and precautions. , 2013, Annals of cardiac anaesthesia.

[68]  V. Boama,et al.  Pseudo (Platelet-type) von Willebrand disease in pregnancy: a case report , 2013, BMC Pregnancy and Childbirth.

[69]  J. Kelton,et al.  A systematic evaluation of laboratory testing for drug‐induced immune thrombocytopenia , 2013, Journal of thrombosis and haemostasis : JTH.

[70]  S. Vesely,et al.  Prevalence of primary immune thrombocytopenia in Oklahoma , 2012, American journal of hematology.

[71]  A. Andriulli,et al.  Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia. , 2012, The New England journal of medicine.

[72]  R. Leyh,et al.  Cardiac surgery in cases of myeloproliferative neoplasm: risk factor for stroke , 2012, Asian cardiovascular & thoracic annals.

[73]  Tao Zhang,et al.  A quantitative comparison of mechanical blood damage parameters in rotary ventricular assist devices: shear stress, exposure time and hemolysis index. , 2012, Journal of biomechanical engineering.

[74]  T. Tedoriya,et al.  Mitral valve repair in a patient with myelodysplastic syndrome. , 2011, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

[75]  S. Jubelirer,et al.  Coronary artery bypass grafting (CABG) in patients with immune thrombocytopenia (ITP): a community hospital experience and review of the literature. , 2011, The West Virginia medical journal.

[76]  V. Roule,et al.  Management of May–Hegglin anomaly referred for coronary artery bypass , 2011, Platelets.

[77]  M. Lacerda,et al.  Thrombocytopenia in malaria: who cares? , 2011, Memorias do Instituto Oswaldo Cruz.

[78]  T. Asada,et al.  Aortic valve replacement and graft replacement of the ascending aorta using deep hypothermic circulatory arrest in a patient with myelodysplastic syndrome. , 2011, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

[79]  I. Dokal.  Inherited bone marrow failure syndromes , 2011 .

[80]  M. Crowther,et al.  The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. , 2011, Blood.

[81]  J. Sabik,et al.  Perioperative management of acquired von Willebrand disease in cardiac surgery: type 2B or not 2B? , 2011, Journal of cardiothoracic and vascular anesthesia.

[82]  G. Srivastava,et al.  Expanding perfusion across disciplines: the use of thrombelastography technology to reduce risk in an obstetrics patient with Gray Platelet Syndrome - a case study , 2011, Perfusion.

[83]  Z. Makahleh,et al.  Off-pump coronary artery bypass grafting in a patient with Bernard-Soulier syndrome. , 2010, The Annals of thoracic surgery.

[84]  T. Ortel,et al.  Plasmapheresis and Heparin Reexposure as a Management Strategy for Cardiac Surgical Patients with Heparin-Induced Thrombocytopenia , 2010, Anesthesia and analgesia.

[85]  J. Panza,et al.  Clinical Implications of Thrombocytopenia Among Patients Undergoing Intra‐aortic Balloon Pump Counterpulsation in the Coronary Care Unit , 2010, Clinical cardiology.

[86]  D. Borjesson,et al.  Anaplasma phagocytophilum and Ehrlichia muris induce cytopenias and global defects in hematopoiesis. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[87]  J. George,et al.  Recurrent acute thrombocytopenia in the hospitalized patient: Sepsis, DIC, HIT, or antibiotic‐induced thrombocytopenia , 2009, American journal of hematology.

[88]  S. Vesely,et al.  Clinical outcomes after platelet transfusions in patients with thrombotic thrombocytopenic purpura , 2009, Transfusion.

[89]  J. Thachil,et al.  Guidelines for the diagnosis and management of disseminated intravascular coagulation , 2009, British journal of haematology.

[90]  J. George,et al.  Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. , 2009, Blood.

[91]  K. Webert,et al.  Consequences of transfusion of platelet antibody: a case report and literature review , 2008, Transfusion.

[92]  Phillip A. Horwitz,et al.  Thrombocytopenia in patients treated with heparin, combination antiplatelet therapy, and intra-aortic balloon pump counterpulsation. , 2008, Journal of interventional cardiology.

[93]  B. Yawn,et al.  von Willebrand disease (VWD): evidence‐based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA) 1 , 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

[94]  Alberto Redaelli,et al.  Platelet Activation Due to Hemodynamic Shear Stresses: Damage Accumulation Model and Comparison to In Vitro Measurements , 2008, ASAIO journal.

[95]  S. Vesely,et al.  Clinical cardiac involvement in thrombotic thrombocytopenic purpura: a systematic review , 2007, Transfusion.

[96]  Ana Cumano,et al.  Ontogeny of the hematopoietic system. , 2007, Annual review of immunology.

[97]  F. Lanza,et al.  Recombinant activated factor VII for hemostatic cover of orthopedic interventions in a girl with thrombocytopenia with absent radii syndrome. , 2007, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[98]  M. Franchini.  Onset of severe refractory thrombocytopenia following surgery in a patient with type 2B von Willebrand disease—A case report , 2006, Hematology.

[99]  P. Lenting,et al.  Shielding of the A1 Domain by the D′D3 Domains of von Willebrand Factor Modulates Its Interaction with Platelet Glycoprotein Ib-IX-V* , 2006, Journal of Biological Chemistry.

[100]  S. Pournaras,et al.  Leptospirosis and pancytopenia: two case reports and review of the literature. , 2005, The Journal of infection.

[101]  A. Pietrabissa,et al.  Thrombosis in the portal venous system after elective laparoscopic splenectomy , 2004, Surgical Endoscopy And Other Interventional Techniques.

[102]  J. Drachman.  Inherited thrombocytopenia: when a low platelet count does not mean ITP. , 2004, Blood.

[103]  R. Gemmell,et al.  Platelet Dysfunction in Myelodysplastic Syndromes: A Clinicopathological Study , 2002, International journal of hematology.

[104]  A. Lichtin,et al.  What is the best way to determine if thrombocytopenia in a patient on multiple medications is drug-induced? , 2002, Cleveland Clinic journal of medicine.

[105]  H. Tilg,et al.  Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. , 2001, Blood.

[106]  W. Wagner,et al.  Assessing acute platelet adhesion on opaque metallic and polymeric biomaterials with fiber optic microscopy. , 2000, Journal of biomedical materials research.

[107]  R. Ariano,et al.  Evaluation and Management of Drug‐Induced Thrombocytopenia in the Acutely Ill Patient , 2000, Pharmacotherapy.

[108]  E. Björnsson,et al.  Plasma thrombopoietin levels in liver cirrhosis and kidney failure , 1999, Journal of internal medicine.

[109]  P. Dunn,et al.  Dissecting aortic aneurysm complicated with acute disseminated intravascular coagulation: case report. , 1999, Changgeng yi xue za zhi.

[110]  K. McCrae,et al.  Posttransfusion purpura: Two unusual cases and a literature review , 1996, American journal of hematology.

[111]  W. Mayr,et al.  Genotyping of the human platelet antigen systems 1 through 5 by multiplex polymerase chain reaction and ligation‐based typing , 1996, Transfusion.

[112]  W. Edwards,et al.  Successful resection of thoracic aortic aneurysms in Wiskott-Aldrich syndrome. , 1995, The Annals of thoracic surgery.

[113]  J Sullivan,et al.  Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy. , 1995, International journal of radiation oncology, biology, physics.

[114]  E. Pivalizza.  Anesthetic management of a patient with thrombotic thrombocytopenic purpura. , 1994, Anesthesia and analgesia.

[115]  D. Oscier,et al.  Establishing the incidence of myelodysplastic syndrome , 1994 .

[116]  S. Peltz.  Severe thrombocytopenia secondary to alcohol use. , 1991, Postgraduate medicine.

[117]  A. Janda,et al.  Heparin management for cardiopulmonary bypass in a patient with disseminated intravascular coagulation. , 1988, Anesthesiology.

[118]  A. Giles,et al.  Type IIB von Willebrand's disease presenting as thrombocytopenia during pregnancy , 1987, British journal of haematology.

[119]  W. Bell,et al.  Post‐transfusion purpura: A report of five patients and a review of the pathogenesis and management , 1986, American journal of hematology.

[120]  J. Marsh.  The effects of cancer chemotherapeutic agents on normal hematopoietic precursor cells: a review. , 1976, Cancer research.

[121]  R. Aster.  PLATELET SEQUESTRATION STUDIES IN MAN , 1972, British journal of haematology.

[122]  R. Wells,et al.  The management and outcomes of patients with myelodysplastic syndrome with persistent severe thrombocytopenia: An observational single centre registry study. , 2019, Leukemia research.

[123]  J. Wiener-Kronish,et al.  Perioperative thrombocytopenia: evidence, evaluation, and emerging therapies , 2019, British journal of anaesthesia.

[124]  E. Golts,et al.  Novel use of cangrelor with heparin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia who require cardiovascular surgery: A case series. , 2019, Seminars in thoracic and cardiovascular surgery.

[125]  Y. Fujio,et al.  The cardioprotective effect of interleukin-11 against ischemia-reperfusion injury in a heart donor model. , 2018, Annals of cardiothoracic surgery.

[126]  J. Spivak.  Myeloproliferative Neoplasms. , 2017, The New England journal of medicine.

[127]  S. Jubelirer,et al.  Thrombotic thrombocytopenic purpura (TTP) following coronary artery bypass: case series and review of the literature. , 2015 .

[128]  T. Miyazaki,et al.  Ischemic Cardiomyopathy with a Rapid Progression from Thrombotic Thrombocytopenic Purpura. , 2015, Internal medicine.

[129]  G. Cimmino,et al.  A Fatal Case of Endocarditis on CoreValve ReValving System Caused by Enterococcus faecium Complicated by Iatrogenic Pancytopenia and Subacute Disseminated Intravascular Coagulation. , 2015, The Journal of heart valve disease.

[130]  A. Abolhoda,et al.  Postoperative thrombotic thrombocytopenic purpura after open heart operations. , 2010, The Annals of thoracic surgery.

[131]  C. McCaul,et al.  Management of a parturient with thrombocytopenia-absent-radius syndrome undergoing urgent caesarean section. , 2008, International journal of obstetric anesthesia.

[132]  A. Hacıhanefioğlu,et al.  Use of recombinant factor VIIa in the management and prophylaxis of bleeding episodes in two patients with Bernard-Soulier syndrome. , 2007, Thrombosis research.

[133]  P. Rebulla,et al.  The risk of bleeding in thrombocytopenic patients with acute myeloid leukemia. , 2006, Haematologica.

[134]  J. Hendry,et al.  Long-term bone marrow damage in experimental systems and in patients after radiation or chemotherapy. , 1985, Anticancer research.

[135]  J. Hines,et al.  Thrombocytopenia of severe alcoholism. , 1971, Annals of internal medicine.

[136]  L. Khachigian,et al.  The role of platelet a-granular proteins in the regulation of thrombopoietin messenger RNA expression in human bone marrow stromal cells , 2022 .